£19,000 Alzheimer’s Drug Blocked for Use on NHS

Published on August 23, 2024

A drug which appears to slow the progression of Alzheimer’s disease was blocked for use on the NHS after being approved by the medicines regulator due to its “marginal” benefits compared to the cost. Lecanemab—made by Japanese company Eisai and branded as Leqembi—was, this week, approved by the Medicines and Healthcare products Regulatory Agency (MHRA), making the treatment the first of its kind to be licensed for use in the UK. But the National Institute for Health and Care Excellence (NICE), which regulates what drugs are allowed to be prescribed on the NHS, said the drug’s benefits were “just too small to justify the significant cost” and that it could only recommend treatments that offered “good value to the taxpayer.”...

Continue reading on website
Other news

Federal Appeals Court Blocks Title IX Gender Rules in 4 States

August 23, 2024
A federal appeals court has blocked the federal government’s expanded Title IX protections based on “gender identity” from taking effect in four states, marking a win for those who argue that the new rules erode protections for women by, for example, allowing biological males who identify as women into women’s locker rooms.In a 2–1 split decision on Aug. 22, the Atlanta-based 11th U.S. Circuit Cou

Listeria Outbreak Linked to Plant-Based Milks Appears to Be Slowing: PHAC

August 23, 2024
The Public Health Agency of Canada says a Listeria outbreak linked to several plant-based milks appears to be slowing down, with no new cases reported in the last two weeks.However, the federal agency’s director of outbreak management says they won’t be comfortable declaring the outbreak over until early October due to Listeria’s incubation period, which can last up to 70 days, and the reporting d